Please ensure Javascript is enabled for purposes of website accessibility

Pharmaceutical Development

Integrated pharmaceutical development services for animal health

Formulation to market, faster

Make go/no-go decisions on solid data to move your animal health product from concept to launch, with pharmaceutical product development services that include analytical, formulation, documentation, clinical, and CMC strategy right from the start.

Talk to our development scientists

Get a risk-based development programme built around your path to approval

Our scientists document every step from analysis to formulation and align with you on regulatory strategy from the start, giving your product the best chance of FDA, EMA, and APVMA approval.

  • Know your risks early: Your development plan includes Quality Target Product Profiles, Critical Quality and Material Attributes, product and process risk assessments, and specification development, borrowed from human health best practices and redesigned for veterinary products.
  • Get a formulation that performs in your target species: Species-specific dissolution profiles, preservative system selection, and in-house palatability testing for companion animal oral products help your product perform in the animals it’s made for.
  • Answer regulatory questions with data you already have: Our flexible SOP framework collects informational data during GMP runs, so you understand your product before you commit to registration.
  • Add regulatory and clinical support when you need it: Bring in our regulatory team to prepare CMC documentation and strategy for your submission, and use our integrated CRO for proof-of-concept, TAS, residue, BEQ, and field-efficacy studies across companion-animal, livestock, and aquaculture species.
Talk to our development scientists

“We had three drug products approved in the span of like a two-year period. Because we collected that data [...] when the FDA came back and asked us questions, we had the answers.”

—Tammy Newbold, CMC consultant
‍

200+ projects supported through to registered products

4 EMA- and FDA-approved GMP manufacturing facilities

5x winner of S&P Global’s Animal Health Award for Best Services Company

Our Services

Development expertise at every stage of your product’s lifecycle

Draw on drug development services built exclusively for animal health, from early feasibility through registration-ready manufacturing.

Early phase development

Make go/no-go decisions on solid data. Assess feasibility, characterise your API, and screen prototypes before you commit to full development.

Formulation development

Optimise dissolution, stability, delivery, and palatability where applicable for the physiology and compliance needs of your target species.

Analytical development

Get stability-indicating methods, in-process controls, and release testing that support your registration.

Process development

Characterise, risk assess, optimise, and validate manufacturing processes from bench through pilot to commercial GMP scale.

Technology transfer

Move your formulation and process into Argenta’s manufacturing infrastructure with full continuity between teams.

Regulatory affairs

Prepare the CMC section of your registration package with support from our animal health regulatory team.

Dosage Forms

What dosage forms can Argenta develop?

Choose the dosage form that fits your species, your route of administration, and where your product will be used, whether that’s the clinic, the home, or the farm.

Oral solids

Develop tablets for companion and livestock species, with dissolution tailored from immediate to extended release.

Soft chews

Give pets a palatable, owner-friendly dose, made with patent-protected extrusion technology.

Learn more

Non-sterile liquids

Formulate oral liquids with preservative systems suited to multi-dose use.

Suspensions

Keep your API evenly dispersed and stable for accurate dosing.

Controlled-release capsules

Deliver long-duration livestock dosing from a single administration, using proprietary gel-former technology.

Learn more

Microspheres

Reduce dosing frequency with tunable extended release for livestock and companion animals.

Learn more

Spot-on tubes

Apply topical treatments easily for companion animals.

Transdermal solutions

Deliver your API through the skin, supported by in-house permeation testing.

Sterile injectables

Develop injectable products, including multi-dose vials with validated preservative systems.

Talk to our development scientists

Why Argenta

Why choose Argenta’s pharmaceutical development services?

Exclusively animal health

Every scientist, facility, and resource at Argenta is dedicated to veterinary pharmaceuticals, so your programme never competes with a human health project.

Catch risks while they’re cheaper to fix

A feasibility-first approach surfaces formulation, regulatory, and scale-up risks early.

Keep one team from concept to commercial

Formulation, clinical supply, process validation, and commercial manufacturing stay with one team, so your product’s history travels with it.

Make registration-ready decisions

Our animal health regulatory team works alongside development scientists from day one, anticipating FDA, EMA, and APVMA requirements.

Engage at one stage or across your full journey

Contract research, pharmaceutical development, and manufacturing work together at Argenta as a single operating model. Wherever you start, every decision on your product is informed by what happens downstream, so you keep your flexibility and stay aligned through to commercial supply.

Talk to our development scientistsExplore the full molecule to market story

Facilities

Develop and manufacture where your markets are

Wherever you develop and sell, you work with one accountable team across Argenta's global footprint.

  • Two formulation development facilities, one in the US and one in New Zealand
  • Four EMA- and FDA-GMP-approved manufacturing facilities
  • AAALAC-accredited ABSL-1 and ABSL-2 facilities in the US and UK [confirm]
  • 125+ commercial products and 600+ SKUs in production
  • Products supplied to more than 50 countries
  • 800+ team members

Related services

Clinical studies

Run VICH-GCP-compliant studies designed around your formulation parameters, across a global clinical site network.
Learn more

Contract manufacturing

Manufacture your formulation at commercial scale across oral solids, soft chews, liquids, and proprietary delivery platforms in FDA/EMA-approved animal health facilities.
Learn more

Argenta technologies

License proprietary soft chew, controlled-release capsule, and microsphere platforms to differentiate a new molecule or extend the life of an existing product.
Explore our technologies

Featured resources

Free fact sheet: Argenta's soft chew technology for animal health products

Download Argenta's soft chew fact sheet to discover the extrusion methodology behind the technology, how it enhances palatability, detailed dissolution information, and how API stability is preserved throughout manufacturing.
Download your fact sheet

eBook: Developing a palatable and effective soft chew for companion animal medicine

Explore the benefits of soft chew technology, the common barriers to creating an effective product, and the strategies to overcome them for a faster, de-risked route to market.
Download the eBook

Drug Delivery Technologies

From palatable soft chews to controlled-release microspheres, discover Argenta's five proprietary, licensable technologies developed exclusively for veterinary applications.
Explore our technologies
Explore all resources

FAQs

Which species do you have experience with in pharmaceutical product development?
Companion animals (dogs, cats), livestock (cattle, sheep), equine, and large animals. Our formulation scientists tailor dissolution, delivery, and, for companion animal oral products, palatability to the physiology and compliance needs of each target species.
Do your pharmaceutical development services span early feasibility through commercial manufacturing?
Yes. Argenta handles formulation development, process development, analytical development, clinical supply manufacturing, process validation, and commercial manufacturing within one organisation. No partner changes or technology transfers required.
What if we only need help with one phase of development?
We scale to your needs. Whether you need a targeted feasibility study, a specific formulation challenge solved, or full end-to-end support, we offer flexible engagement models.
How is Argenta different from a human health CDMO?
Every resource at Argenta is dedicated to animal health, so your project never competes with a human health programme for capacity. Your formulation is developed by scientists with deep experience in species-specific formulation, veterinary preservative systems, and animal health-specific APIs.
What regulatory bodies do you have experience with?
FDA CVM, EMA, APVMA, and EFSA. Our dedicated regulatory team specialises in animal health product regulations and designs VICH-aligned CMC and clinical strategies from day one.
How do you handle data collection during GMP manufacturing runs?
Our experience-driven SOP framework enables the collection of data during GMP runs that many CDMOs refuse to handle. This data is critical for setting specifications, understanding product behaviour, and proactively answering regulatory questions.
Do you have clinical study capabilities?
Yes. We help sponsors plan and execute VICH-GCP-compliant preclinical and clinical studies through our integrated CRO, with clinical site networks across geographies and shared data between your clinical and development teams.
Healthy animals. Let’s make it happen, together.
Get the expertise and capabilities you need to bring your animal health product to life, from formulation to commercial manufacturing.
Talk to our development scientists